Life Science Webinars

  1. Looking Under The Hood Of The Unified Lab

    Striving to bring the way we acquire, share and gain insights from scientific data, through a community and the framework for standardization and linked data.

  2. Solvents, Polymers & Cyclones: Bioavailability Enhancement Through Spray-Dried Dispersions

    Very few new molecular entities in active clinical development are readily bioavailable, and when dosed at escalated levels, even these may not be sufficiently absorbed. Learn how spray-dried amorphous dispersion might help.

  3. How Turnkey Facility And Cleanroom Solutions Are Transforming Pharmaceutical And Biopharmaceutical Manufacturing

    This webinar highlights the need to evolve to more flexible and modular facility designs that can be built in a factory, shipped to the site and then rapidly assembled how it is being addressed by innovative suppliers in different ways.

  4. Orally Disintegrating Tablet (ODT): A Patient-Centric Dosage Form

    As compared to IV route, ODT can provide a convenient oral route of administration for proteins, peptides and vaccines. Join experts from Catalent for an overview of the challenges and opportunities in using ODT technology as a patient-centric drug delivery tool and get updates on the new developments in ODT technology including delivery of peptides and vaccines.

  5. Challenges And Opportunities In The Development Of Biologic Drugs

    With transformational changes in biologics, there are increasingly newer formats of new biologic drugs including bispecific antibodies, antibody drug conjugates and antibody-peptide fusion proteins.

  6. Optimize Biologic Drug Development With The Power Of Scientific Informatics

    The complex structure of Biologics, the nature of the interactions with their partners, require accurate modelling method to predict their physicochemical properties.

  7. GS1 DataMatrix Barcode Grading

    Recent US and EU serialization mandates have introduced the GS1 DataMatrix barcode symbology into a much wider role in the pharmaceutical supply chain.

  8. Developing Site-Specifically Modified ADCs Using A Chemoenzymatic Approach

    Antibody-drug conjugates (ADCs) have become de rigueur for pharmaceutical oncology drug development pipelines. There are more than 40 ADCs undergoing clinical trials and many more in preclinical development. Get the latest on novel protein modification platform and its application to generate ADCs, including new conjugation chemistries and linkers.

  9. Get To Clinic Faster: Navigating Complex Biologics Through Development And Manufacturing

    With the increasing complexity of biologics and growing competition, a comprehensive approach involving advanced drug delivery and development technologies, as well as cutting-edge analytical techniques is needed to support development goals. Learn about the strategies to drive biologics and biosimilar development programs and meet aggressive development timelines.

  10. Should Your Next Clinical Trial Use A New Supply Model?

    Clinical supply models need to provide for an adequate supply of patient kits that allow for variations in patient recruitment levels and clinical site activity.